The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1 Progression
Open accessAbstract
The immunosuppressant rapamycin, in complex with its cellular receptor FKBP12, targets the cellular protein FKBP12-rapamycin-associated protein/mammalian target of rapamycin/rapamycin and FKBP12 target 1 (FRAP/mTOR/RAFT1) and inhibits/delays G1 cell cycle progression in mammalian cells. As a member of the novel phosphatidylinositol kinase-related kinase family, FRAP's kinase activity is essential for its signaling function. The FKBP12-rapamycin binding (FRB) domain in FRAP is also speculated to play an important role in FRAP function and signaling. However, the biochemical and physiological functions of FRB, as well as the mechanism for rapamycin inhibition, have been unclear. The present study focuses on investigation of FRB's role and the functional relationship between FRB domain and kinase domain in FRAP. Microinjection of purified FRB protein into human osteosarcoma MG63 cells results in a drastic blockage of the G1 to S cell cycle progression; such a dominant negative effect is reversed by a point mutation (Trp2027 --> Phe). The same mutation also abolishes kinase activity of FRAP without affecting ATP binding, and truncation studies suggest that upstream sequences including FRB are required for kinase activity in vitro. Given these data, we propose a model for FRAP function, in which the FRB domain is required for activation of the kinase domain, possibly through the interaction with an upstream activator. In addition, our observations provide direct evidence linking FRAP function to G1 cell cycle progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, however, the kinase N-lobe features a large insertion corresponding to the FKBP12-rapamycin binding (FRB) domain (Chen et al., 1995; Chiu et al., 1994; Vilella-Bach et al., 1999) specific to mTORC1 among the PIKKs.”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Vilella-Bach et al., 1999
Citations
Cites
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., BELHAM, C. M., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,370
Pause, A., Belsham, G. J., Gingras, A., Donzé, O., Lin, T.-A., Lawrence, J. C., & Sonenberg, N. (1994) · Nature · doi:10.1038/371762a0 · Cited by 1,242
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,130
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 933
Self-citationIsolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Gingras, A., Kennedy, S. G., O'Leary, M., Sonenberg, N., & Hay, N. (1998) · Genes & Development · doi:10.1101/gad.12.4.502 · Cited by 885
Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
Kunz, J., Henríquez, R., Schneider, U., Deuter‐Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 838
Brunn, G. J., Williams, J. M., Sabers, C. J., Wiederrecht, G., Lawrence, J. C., & Abraham, R. T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00911.x · Cited by 715
TOR controls translation initiation and early G1 progression in yeast.
Barbet, N., Schneider, U., Helliwell, S. B., Stansfield, I., Tuite, M. F., & Hall, M. N. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.1.25 · Cited by 710
Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G. R., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 706
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
Self-citationStarting at the Beginning, Middle, and End: Translation Initiation in Eukaryotes
Sachs, A. B., Sarnow, P., & Hentze, M. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80268-8 · Cited by 679
PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation
Lin, T.-A., Kong, X., Haystead, T., Pause, A., Belsham, G. J., Sonenberg, N., & Lawrence, J. C. (1994) · Science · doi:10.1126/science.7939721 · Cited by 671
Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
Jefferies, H. B. J., Reinhard, C., Kozma, S. C., & Thomas, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4441 · Cited by 623
Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase
Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992) · Nature · doi:10.1038/358070a0 · Cited by 594
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4947 · Cited by 556
Self-citationRegulation of eIF-4E BP1 Phosphorylation by mTOR
Hara, K., Yonezawa, K., Kozlowski, M. T., Sugimoto, T., Andrabi, K. I., Weng, Q.-P., Kasuga, M., Nishimoto, I., & Avruch, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26457 · Cited by 522
PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints
Keith, C. T., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.270.5233.50 · Cited by 521
Scott, P., Brunn, G. J., Kohn, A. D., Roth, R. A., & Lawrence, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7772 · Cited by 482
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Helliwell, S. B., Wagner, P., Kunz, J., Deuter‐Reinhard, M., Henríquez, R., & Hall, M. N. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.1.105 · Cited by 390
A Signaling Pathway to Translational Control
Brown, E. J., & Schreiber, S. L. (1996) · Cell · doi:10.1016/s0092-8674(00)80125-7 · Cited by 364
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Terada, N., Patel, H. R., Takase, K., Kohno, K., Nairn, A. C., & Gelfand, E. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11477 · Cited by 353
Cafferkey, R., Young, P. R., McLaughlin, M. M., Bergsma, D. J., Koltin, Y., Sathe, G. M., Faucette, L. F., Eng, W.-K., Johnson, R. K., & Livi, G. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6012-6023.1993 · Cited by 309
When is a lipid kinase not a lipid kinase? When it is a protein kinase
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90225-2 · Cited by 306
Zheng, X.-F., Fiorentino, D. F., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995) · Cell · doi:10.1016/0092-8674(95)90058-6 · Cited by 300
Self-citationSchmidt, A., Bickle, M., Beck, T. W., & Hall, M. N. (1997) · Cell · doi:10.1016/s0092-8674(00)81893-0 · Cited by 300
ATM-related genes: What do they tell us about functions of the human gene?
Zakian, V. A. (1995) · Cell · doi:10.1016/0092-8674(95)90463-8 · Cited by 271
TOR2 is required for organization of the actin cytoskeleton in yeast
Schmidt, A., Kunz, J., & Hall, M. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13780 · Cited by 264
Koltin, Y., Faucette, L. F., Bergsma, D. J., Levy, M. A., Cafferkey, R., Koser, P. L., Johnson, R. K., & Livi, G. P. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1718-1723.1991 · Cited by 249
The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling
Chou, M. M., & Blenis, J. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80064-6 · Cited by 237
Control of PHAS-I by Insulin in 3T3-L1 Adipocytes
Lin, T.-A., Kong, X., Saltiel, A. R., Blackshear, P. J., & Lawrence, J. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18531 · Cited by 237
Graves, L. M., Bornfeldt, K., Argast, G. M., Krebs, E. G., Kong, X., Lin, T. A., & Lawrence, J. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7222 · Cited by 220
A template for the protein kinase family
Taylor, S. S., Knighton, D. R., Zheng, J., Sowadski, J. M., Gibbs, C. S., & Zoller, M. J. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)80001-r · Cited by 194
Brunn, G. J., Fadden, P., Haystead, T., & Lawrence, J. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32547 · Cited by 167
Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway
Nielsen, F. C., Østergaard, L., Nielsen, J., & Christiansen, J. (1995) · Nature · doi:10.1038/377358a0 · Cited by 163
S6 Phosphorylation and the p70 s6k /p85 s6k
Ferrari, S. M., & Thomas, G. (1994) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239409083485 · Cited by 146
Albers, M. W., Williams, R. T., Brown, E. J., Tanaka, A., Hall, F. L., & Schreiber, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41602-x · Cited by 145
Hu, C., Pang, S., Kong, X., Velleca, M., & Lawrence, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3730 · Cited by 137
Terada, N., Takase, K., Papst, P. J., Nairn, A. C., & Gelfand, E. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3418 · Cited by 75
Cancer Predisposition: Ataxia–telangiectasia at the crossroads
Jackson, S. P. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00238-7 · Cited by 48
(2008) · Springer eBooks · doi:10.1007/978-1-4020-6754-9_17317 · Cited by 47
Withers, D. J., Seufferlein, T. T. W., Mann, D. J., García, B., Jones, N. C., & Rozengurt, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2509 · Cited by 39
Flagged first, then by citations
Research works printed but not linked: 2
- Koltin, 1991, Mol. Cell. Biol., 11, 1718
- Cafferkey, 1993, Mol. Cell. Biol., 13, 6012
Cited by
Sorted by citations
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,773
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
mTOR kinase structure, mechanism and regulation
Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., & Pavletich, N. P. (2013) · Nature · doi:10.1038/nature12122 · Cited by 1,075
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Self-citationFingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L. A., Tsou, C., & Blenis, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.200-216.2004 · Cited by 884
Metadata
- Authors
- Vilella-Bach, M., Nuzzi, P., Fang, Y., & Chen, J.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Chen, Jie
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 274
- Issue
- 7
- Pages
- 4266-4272
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2000281583
- Cited by
- 154
- References
- 48
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 8 · 2014: 3 · 2013: 9 · 2012: 3
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- FRAP, mTOR, G1 cell cycle progression, rapamycin, immunosuppressants, dominant negative effect, osteosarcoma cells, ATP binding
- MeSH terms
- Amino Acid Sequence, Binding Sites, Carrier Proteins, Catalysis, Cell Line, Humans, Immunosuppressive Agents, Microinjections, Molecular Sequence Data, Protein Kinases, Serine, Tryptophan, Tumor Cells, Cultured, G1 Phase, S Phase, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Phosphotransferases (Alcohol Group Acceptor), Phosphatidylinositol 3-Kinases, Amino Acid Substitution, Immunophilins, Sirolimus, Tacrolimus Binding Proteins, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review